Cargando…
ASAP ECMO: Antibiotic, Sedative and Analgesic Pharmacokinetics during Extracorporeal Membrane Oxygenation: a multi-centre study to optimise drug therapy during ECMO
BACKGROUND: Given the expanding scope of extracorporeal membrane oxygenation (ECMO) and its variable impact on drug pharmacokinetics as observed in neonatal studies, it is imperative that the effects of the device on the drugs commonly prescribed in the intensive care unit (ICU) are further investig...
Autores principales: | Shekar, Kiran, Roberts, Jason A, Welch, Susan, Buscher, Hergen, Rudham, Sam, Burrows, Fay, Ghassabian, Sussan, Wallis, Steven C, Levkovich, Bianca, Pellegrino, Vin, McGuinness, Shay, Parke, Rachael, Gilder, Eileen, Barnett, Adrian G, Walsham, James, Mullany, Daniel V, Fung, Yoke L, Smith, Maree T, Fraser, John F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3543712/ https://www.ncbi.nlm.nih.gov/pubmed/23190792 http://dx.doi.org/10.1186/1471-2253-12-29 |
Ejemplares similares
-
Population Pharmacokinetics and Dosing Simulations of Ceftriaxone in Critically Ill Patients Receiving Extracorporeal Membrane Oxygenation (An ASAP ECMO Study)
por: Cheng, Vesa, et al.
Publicado: (2022) -
The ECMO PK Project: an incremental research approach to advance understanding of the pharmacokinetic alterations and improve patient outcomes during extracorporeal membrane oxygenation
por: Shekar, Kiran, et al.
Publicado: (2013) -
Sequestration of drugs in the circuit may lead to therapeutic failure during extracorporeal membrane oxygenation
por: Shekar, Kiran, et al.
Publicado: (2012) -
Cytokine adsorption during ECMO for COVID-19-related ARDS
por: Shekar, Kiran, et al.
Publicado: (2021) -
Commentary: To ECMO or not to ECMO: That is the question
por: Worku, Berhane, et al.
Publicado: (2020)